Set up Desano.

Set up R&D team to research and develop APIs of ARVs, oncology and steroids.

Formulations of ARV generic drugs were developed.

APIs and Formulations were manufactured and commercialized.

ARV generic drugs manufactured obtained market authorization in China.

Two Subsidiary pharmaceutical companies got GMP certificate to become one of the first domestic supplier of ARV generic drugs in China.

Set up overseas branches to introduce Desano's brand internationally.

R&D Center is honored to be Shanghai Enterprise Technology Center.

ARV APIs production site achieved WHO Pre-qualification.

New manufacturing sites of APIs and FPPs are established and started to run